1-4 of 4
Enrique Colado, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Sergio Matarraz, Pilar Leoz, Xavier Calvo, MD PhD, Luis García Alonso, Rosa Ayala Bueno, José Ignacio Sánchez-Gallego, PhD, Neus Villamor, Enrique Colado, MD PhD, María Belén Vidriales, María Isabel Prieto Conde, Maria Carmen Chillon, Ramón García-Sanz, MD PhD, Vincent H.J. Van Der Velden, PhD, Félix López Cadenas, MD, María Díez-Campelo, MD PhD, Leonor Arenillas, MD PhD, Sara Alonso, MD, Ariana Fonseca, Covadonga Quirós Caso, Laura Magnano, José Antonio Garcia Vela, MD, Carlos Fernandez, Daniela Damasceno, Andrea Mayado, Susana Barrena, PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2687.
https://doi.org/10.1182/blood-2019-131733
Published: 2019
Journal Articles

Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Olga Pérez-López, MD, Teresa Caballero-Velázquez, MD PhD, Enrique Colado, MD PhD, Sara Alonso, MD, José González-Campos, MD, Concepción Prats-Martín, MD, Nancy Rodríguez-Torres, MD, Virginia Escamilla Gomez, Ildefonso Espigado, MD PhD, Jose Antonio Pérez-Simón
Journal: Blood
Blood (2018) 132 (Supplement 1): 5733.
https://doi.org/10.1182/blood-2018-99-119437
Published: 2018
Journal Articles

VAMP/ThaCyDex: Velcade® (Bortezomib), Adriamycin, Melphalan and Prednisone Alternating with Thalidomide, Cyclophosphamide and Dexametasone as a Salvage Regimen in Relapsed Multiple Myeloma Patients

Enrique Colado, MD, Maria-Victoria Mateos, MD, PhD, Maria-Jose Moreno, MD, Felipe de Arriba, MD, Javier de la Rubia, MD, Juan José Lahuerta, MD, PhD, Pastora Iniesta, MD, Maria Cruz Viguria, MD, Ana Pilar Gonzalez, MD, Ramón García-Sanz, MD, PhD, Juan Olazabal, MD, Jesús F San Miguel
Journal: Blood
Blood (2008) 112 (11): 3694.
https://doi.org/10.1182/blood.V112.11.3694.3694
Published: 2008
Journal Articles

Proteasome Inhibitor Bortezomib Has Antitumour Activity Against Both CD34 Negative and CD34 Positive Acute Myeloid Leukemia Cells.

Enrique Colado, MD, Jesus Martin, MD, Maria-Belen Vidriales, MD,PhD, Atanasio Pandiella, MD,PhD, Dixie-Lee Esseltine, MD,FRCPC, Jose J. Perez, Enrique M. Ocio, MD,PhD, J.F. San Miguel, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1989.
https://doi.org/10.1182/blood.V108.11.1989.1989
Published: 2006